You can safely skip the LDH and save thousands
December 1, 1997 3 minutes read
You can safely skip the LDH and save thousands
UR study calls for eliminating routine LDH tests
When Walter Reed Army Medical Center removed routine lactate dehydrogenase (LDH) tests from its rule out myocardial infarction (MI) protocols, the Washington, DC, hospital saved nearly $47,000 the first year with no adverse effects on patients.1 The change was made after a utilization review study concluded that LDH testing did not add clinically useful data in diagnosing patients for MI.
In the study, researchers examined 200 patients with one or more abnormal cardiac isoenzyme finding. They also surveyed 100 hospitals and found that 66% routinely perform the LDH test as part of their heart attack protocol despite the fact that national guidelines have recommended against routine LDH testing since 1990.
When Walter Reed staff began reviewing blood tests, they saw that LDH tests were done routinely on all patients to rule out MI, but the information wasn’t being used, says Capt. Daniel C. Randall, MD, of the U.S. Army Medical Corps, now stationed at Madigan Army Medical Center in Tacoma, WA. Guidelines endorsed by the Ameri-can Heart Association, American College of Physicians, and American College of Cardiology have recommended against administering LDH tests unless patients have had chest pain for more than 24 hours and creatine kinase isoenzyme-MB (CK-MB) enzyme tests are negative.2
"We knew that was a very small subset of patients. We looked back over a year to determine how many patients had LDH drawn and how many were positive," Randall says.
Randall and his co-researcher, Lt. Col. David L. Jones, MD, studied other blood tests given to patients and determined that in every single test when the LDH enzyme showed positive, the patient also had a positive CK-MB test. So the LDH test was removed from the heart attack protocol at Walter Reed.
"We said it was still available for the doctors to use, but we didn’t stress it," Randall says. During the next year, only 14 LDH tests were performed, and none was positive. The previous year, 6,177 tests had been performed at a cost of $47,000.
In addition to cutting the annual expenditure for LDH tests by 99%, the change in protocol allowed the laboratory staff to provide a faster turnaround for other tests, Randall adds. Because Walter Reed is a military hospital and can get supplies at a discount, the tests cost only $7.77 each. Civilian hospitals might charge as much as $20 for the tests, nearly tripling their savings.
After the utilization review project at Walter Reed, Randall and Jones made scripted telephone calls to 50 hospitals, mostly military and teaching hospitals. They asked if staff were automatically using the LDH test for heart attack patients. Of 50 hospitals called, 32 responded positively. The researchers called an additional 50 hospitals, randomly chosen from the American Hospital Association guide. Of those, 34 were using the LDH tests on a routine basis. Overall, 66% of hospitals surveyed were automatically using the LDH tests. Nearly three-quarters of hospitals affiliated with medical schools were using the test; 62% not affiliated with medical schools routinely used the tests.
"My assertion, which is supported by the utilization review study, is that the LDH test is not needed. If the CK-MB test is positive, the patient almost certainly had a heart attack, and another test is not needed," Randall says.
LDH levels in the blood increase only after 24 to 48 hours following a heart attack, but they remain elevated for 72 to 144 hours. "Most patients don’t wait three or four days to come in to the hospital if they have chest pain. Hospitals should screen out those patients whose the pain started during admission and use that information to determine what tests are needed," he says.
A positive LDH test can indicate pneumonia, a blood clot in the lung, or other conditions, Randall says. Other studies have shown a person is three times more likely to have a false-positive elevated LDH than a true-positive LDH test, he adds.
Not only does this test waste resources, says Randall, but new tests, such as the troponin test, are more sensitive and more specific indicators of whether a person has a heart attack.
References
1. Randall DC, Jones DL. Eliminating unnecessary lactate dehydrogenase testing: A utilization review study and national survey. Arch Inter Med 1997; 157:1,441-1,444.
2. Gunnar RM, Passmania ER, Bourdillon PD, et al. Guidelines for the early management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for Early Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol 1990; 16:249-292.
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content